Digiovanni Jeffrey J, Pratt Ryan M
Communication Sciences and Disorders, Ohio University, Athens, OH, USA.
J Am Acad Audiol. 2010 Nov-Dec;21(10):663-70. doi: 10.3766/jaaa.21.10.6.
Accurate prescriptive gain results in a more accurate fit, lower return rate in hearing aids, and increased patient satisfaction. In situ threshold measurements can be used to determine required gain. The Widex Corporation uses an in situ threshold measurement strategy, called the Sensogram. Real-ear measurements determine if prescriptive gain targets have been achieved. Starkey Laboratories introduced an integrated real-ear measurement system in their hearing aids.
To determine whether the responses obtained using the Widex Sensogram were equivalent to those obtained using current clinical threshold measurement methods. To determine the accuracy of the Starkey IREMS™ (Integrated Real Ear Measurement System) in measuring RECD (real-ear to coupler difference) values compared to a dedicated real-ear measurement system.
A verification design was employed by comparing participant data measured from standard, benchmark equipment and procedures against new techniques offered by hearing-aid manufacturers.
A total of 20 participants participated in this study. Ten participants with sensorineural hearing loss were recruited from the Ohio University Hearing, Speech, and Language Clinic participated in the first experiment. Ten participants with normal hearing were recruited from the student population at Ohio University participated in both experiments. The normal-hearing group had thresholds of 15 dB HL or better at the octave frequencies of 250-8000 Hz. The hearing-impaired group had thresholds of varying degrees and configurations with thresholds equal to or poorer than 25 dB HL three-frequency pure-tone average.
The order of measurement method for both experiments was counterbalanced. In Experiment 1, thresholds obtained via the Widex Sensogram were compared to thresholds obtained for each participant using a clinical audiometer and ER-3A insert ear phones. In Experiment 2, RECD values obtained via the Starkey IREMS were compared to RECD values obtained via the Audioscan Verifit™. A repeated-measures analysis of variance (ANOVA) was used for statistical analysis, and a Fisher's LSD (least significant difference) was used as a post hoc analysis tool.
A significant difference between Sensogram thresholds and conventional audiometric thresholds was found with the Sensogram method resulting in better threshold values at 0.5, 1.0, and 2.0 kHz for both groups. In Experiment 2, a significant difference between RECD values obtained by the Starkey IREMS and the Audioscan Verifit system was found with significant differences in RECD values found at 0.25, 0.5, 0.75, 1.5, 2.0, and 6.0 kHz.
The Sensogram data differ significantly from traditional audiometry at several frequencies important for speech intelligibility. Real-ear measures are still required for verification of prescribed gain, however, calling into question any claims of shortened fitting time. The Starkey IREMS does perform real-ear measurements that vary significantly from benchmark equipment. These technologies represent a positive direction in prescribing accurate gain during hearing-aid fittings, but a stand-alone system is still the preferred method for real-ear measurements in hearing-aid fittings.
精确的处方增益可带来更精确的适配、更低的助听器返修率以及更高的患者满意度。原位阈值测量可用于确定所需增益。Widex公司采用一种称为“灵敏图”的原位阈值测量策略。真耳测量可确定是否达到了处方增益目标。斯达克听力技术公司在其助听器中引入了一种集成真耳测量系统。
确定使用Widex灵敏图获得的反应是否等同于使用当前临床阈值测量方法获得的反应。确定与专用真耳测量系统相比,斯达克IREMS™(集成真耳测量系统)在测量真耳到耦合器差值(RECD)时的准确性。
通过将从标准、基准设备和程序测量的参与者数据与助听器制造商提供的新技术进行比较,采用了验证设计。
共有20名参与者参与了本研究。从俄亥俄大学听力、言语和语言诊所招募了10名感音神经性听力损失患者参与第一个实验。从俄亥俄大学学生群体中招募了10名听力正常的参与者参与两个实验。听力正常组在250 - 8000 Hz倍频程频率下的阈值为15 dB HL或更好。听力受损组阈值程度和构型各异,三频率纯音平均阈值等于或低于25 dB HL。
两个实验的测量方法顺序均进行了平衡。在实验1中,将通过Widex灵敏图获得的阈值与使用临床听力计和ER - 3A插入式耳机为每个参与者获得的阈值进行比较。在实验2中,将通过斯达克IREMS获得的RECD值与通过Audioscan Verifit™获得的RECD值进行比较。采用重复测量方差分析(ANOVA)进行统计分析,并使用Fisher最小显著差异法(LSD)作为事后分析工具。
发现灵敏图阈值与传统听力阈值之间存在显著差异,灵敏图方法在0.5、1.0和2.0 kHz时为两组均带来了更好的阈值。在实验2中,发现斯达克IREMS获得的RECD值与Audioscan Verifit系统获得的RECD值之间存在显著差异,在0.25、0.5、0.75、1.5、2.0和6.0 kHz时RECD值存在显著差异。
在对言语可懂度重要的几个频率上,灵敏图数据与传统听力测量有显著差异。然而,仍需要真耳测量来验证处方增益,这对任何缩短验配时间的说法提出了质疑。斯达克IREMS确实能进行真耳测量,但其测量结果与基准设备有显著差异。这些技术在助听器验配过程中规定精确增益方面代表了一个积极的方向,但独立系统仍是助听器验配中真耳测量最优选的方法。